Back to results
US 2026/0097109 A1Published application
HPV Virus-Like Particle Bioconjugates
AssigneeInventprise, LLC
InventorSubhash V. Kapre
Life of this patent
Estimating the term…
Abstract
This invention is directed to immunogenic composition, vaccines and conjugates comprising virus-lie particles (VLP) compositions conjugated to one or more L2 proteins of HPV. The invention further includes methods for the manufacture of immunogenic compositions and vaccines and methods for the treatment and/or prevention of HPV infection.
Claims15
An immunogenic composition comprising virus-like particles (VLPs) of HPV L1 protein conjugated to one or more types of HPV L2 protein.
The method of claim 12, further comprising adding an adjuvant.
Dependencies are inferred from the claim text.